Subsea7 Announces Major Project Under Agreement With Aramco
ZACKS· 2025-09-16 22:31
Key Takeaways Subsea7 won a major Aramco contract for offshore pipeline installation and facility modifications.The deal includes 106 km of infield and export pipelines plus topside modifications and hook-up activities.Engineering begins immediately, with offshore activities set to start between 2027 and 2028.Subsea7 S.A. (SUBCY) has received a new project under its long-term agreement (LTA) with Saudi Arabia’s energy giant Aramco. Per the terms of the new contract, Subsea7 will cover the engineering, procu ...
Should You Invest in Carnival (CCL) Based on Bullish Wall Street Views?
ZACKS· 2025-09-16 22:31
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about Carnival (CCL) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Carnival currently has an average brokerage recommendation (ABR) ...
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?
ZACKS· 2025-09-16 22:31
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Merck (MRK) .Merck currently has an average brokerage recommendat ...
Aurora And Copeia Launches English-language version of the Physician Experience Platform (PEP)
Yahoo Finance· 2025-09-16 22:31
Aurora Cannabis Inc. (NASDAQ:ACB) is among the 12 Best Marijuana Stocks to Buy According to Analysts. Aurora Cannabis Inc. (NASDAQ:ACB) and German healthcare technology company Copeia have released an English-language version of the Physician Experience Platform (PEP). The platform has over 130 anonymized case studies detailing real-world medicinal cannabis treatments, including patient history, symptoms, dose, outcomes, and concurrent medicines. PEP, which is initially available in Canada, the United King ...
Why UnitedHealth (UNH) is a Top Pick for Investors Seeking Consistent Dividends
Yahoo Finance· 2025-09-16 22:30
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 13 Best Consistent Dividend Stocks to Buy Now. Why UnitedHealth (UNH) is a Top Pick for Investors Seeking Consistent Dividends UnitedHealth Group Incorporated (NYSE:UNH) is an American multinational health insurance and healthcare company. The stock is down by over 30% since the start of 2025; however, it surged by nearly 30% in August only. UnitedHealth Group Incorporated (NYSE:UNH) is the leading health insurer in the US, with operations ...
ScottsMiracle-Gro’s 2025 Corporate Responsibility Report Highlights Gains In Packaging, Waste and Water Conservation
Yahoo Finance· 2025-09-16 22:30
The Scotts Miracle-Gro Company (NYSE:SMG) is among the 12 Best Marijuana Stocks to Buy According to Analysts. The Scotts Miracle-Gro Company (NYSE:SMG) made major strides toward sustainability and ESG targets in its 2025 Corporate Responsibility Report. Key accomplishments for the company included diverting 1.76 million pounds of coir waste for industrial and agricultural use, reducing virgin plastic with Ortho brand reusable pouches, and achieving 100% recyclable packaging for its O.M. Scott & Sons brand. ...
UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says
CNBC· 2025-09-16 22:30
Dave Ricks, chair and chief executive officer of Eli Lilly and Company speaks to the Economic Club of New York in New York City, U.S., March 12, 2024.U.S. policymakers should take note as biopharmaceutical companies pull back on investments in the U.K., Eli Lilly Chief Executive Officer Dave Ricks said in an interview with CNBC.Lilly recently paused plans to create a biotech incubator called Gateway Labs in the U.K., joining other biopharma companies that have put investments in the country on hold amid con ...
IF Bancorp: Potentially Interesting, But Just A Hold For Now (NASDAQ:IROQ)
Seeking Alpha· 2025-09-16 22:30
IF Bancorp (NASDAQ: IROQ ) is the holding company for Iroquois Federal Savings and Loan Association, headquartered in Illinois. This is a small local bank with just seven branches in Illinois and a loan production office inHe is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable research on appealing Europe-focused investment opportunities not found elsewhere. The a focus is on high-quality ideas in the small-cap space, with emphasis on capital gains and ...
Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer drugs, other treatments
CNBC· 2025-09-16 22:30
Eli Lilly on Tuesday said it will spend $5 billion to build a manufacturing facility in Goochland County, Virginia, to boost production capacity for targeted cancer drugs and other treatments – the first in a string of new planned U.S. investments by the drugmaker. The company announced in February that it would spend at least $27 billion to build four new domestic manufacturing plants, adding to $23 billion in previous investments since 2020. Eli Lilly said it will announce the three remaining U.S. sites t ...
Biofrontera Inc. Announces Last Patient Out in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Photodynamic Therapy (PDT) for the Treatment of Actinic Keratoses (AK) on the Extremities, Neck and Trunk
Globenewswire· 2025-09-16 22:30
All 172 patients have now entered the 12-month follow-up phaseTrial involves larger surface areas, building on the approval in October 2024 for use of up to 3 tubes of Ameluz® per treatmentStudy results expected to form the basis of a supplemental New Drug Application (sNDA) planned for submission in Q2 2026 WOBURN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of p ...